SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QGLY - Funny Name Great Product. -- Ignore unavailable to you. Want to Upgrade?


To: James M. Bash who wrote (8857)4/21/1999 12:36:00 PM
From: J R KARY  Respond to of 8960
 
Motley Fool doesn't "buy" QGLY's sales

Views them as nonrecurring:

" Investors who followed the rise and fall of Cold-Eeze lozenge maker Quigley (Nasdaq:QGLY - news) , Breathe Right nasal strip producer CNS (Nasdaq:CNXS - news) and even Iomega (NYSE:IOM - news) had already lived through this when those shares surged ahead with exuberant sales as new exciting products began to fill the distribution channels.

Once they maxed out the retail outlets, the heady growth came to an end. History repeats itself. It did with Balance Bar.

fnews.yahoo.com

MF then asks : " WHERE TO FROM HERE? "

Jim K



To: James M. Bash who wrote (8857)4/21/1999 4:49:00 PM
From: drakes353  Read Replies (1) | Respond to of 8960
 
James:

Really does make you wonder where the stock would be without QGLY in there buying.

drakes353



To: James M. Bash who wrote (8857)4/21/1999 5:40:00 PM
From: Ironyman  Respond to of 8960
 
No disrespect intended, but this is the deadest stock around.